TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Brief Summary: The purpose of this Randomized, Double-blind, Multicenter, Two-period Crossover Study is to Assess the Efficacy and Tolerability of Burlulipase (NM-BL) in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis


Options:
A: Arm Label: GLP-1 Incretin Hormone; Type: EXPERIMENTAL; Interventions: Drug: GLP-1 | Arm Label: GIP Incretin Hormone; Type: EXPERIMENTAL; Interventions: Drug: GIP | Intervention Type: DRUG; Name: GLP-1; Assigned to Arm(s): GLP-1 Incretin Hormone | Intervention Type: DRUG; Name: GIP; Assigned to Arm(s): GIP Incretin Hormone
B: Arm Label: EUR-1008 then Kreon; Type: EXPERIMENTAL; Interventions: Drug: EUR-1008 25,000 Units, Drug: Kreon 25,000 Units | Arm Label: Kreon then EUR-1008; Type: EXPERIMENTAL; Interventions: Drug: EUR-1008 25,000 Units, Drug: Kreon 25,000 Units | Intervention Type: DRUG; Name: EUR-1008 25,000 Units; Assigned to Arm(s): EUR-1008 then Kreon, Kreon then EUR-1008 | Intervention Type: DRUG; Name: Kreon 25,000 Units; Assigned to Arm(s): EUR-1008 then Kreon, Kreon then EUR-1008
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Pancrelipase Delayed Release | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Comparator | Intervention Type: DRUG; Name: Pancrelipase Delayed Release; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo Comparator; Assigned to Arm(s): B
D: Arm Label: Burlulipase; Type: EXPERIMENTAL; Interventions: Drug: Burlulipase | Arm Label: Placebo (Caramel in sterile water); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (Caramel in sterile water) | Intervention Type: DRUG; Name: Burlulipase; Assigned to Arm(s): Burlulipase | Intervention Type: DRUG; Name: Placebo (Caramel in sterile water); Assigned to Arm(s): Placebo (Caramel in sterile water)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man
Brief Summary: The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.


Options:
A: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin, Behavioral: Lifestyle intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Lifestyle intervention | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Metformin, Placebo
B: Arm Label: caffeine and ephedrine; Type: EXPERIMENTAL; Interventions: Drug: caffeine and ephedrine | Arm Label: leptin A; Type: EXPERIMENTAL; Interventions: Drug: Leptin A | Arm Label: caffeine, ephedrine, and leptin A; Type: EXPERIMENTAL; Interventions: Drug: caffeine, ephedrine, and leptin A | Intervention Type: DRUG; Name: caffeine and ephedrine; Assigned to Arm(s): caffeine and ephedrine | Intervention Type: DRUG; Name: Leptin A; Assigned to Arm(s): leptin A | Intervention Type: DRUG; Name: caffeine, ephedrine, and leptin A; Assigned to Arm(s): caffeine, ephedrine, and leptin A
C: N/A
D: Arm Label: Sibutramine; Type: EXPERIMENTAL; Interventions: Drug: Sibutramine hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Lead-in sibutramine; Type: EXPERIMENTAL; Interventions: Drug: Sibutramine hydrochloride | Intervention Type: DRUG; Name: Sibutramine hydrochloride; Assigned to Arm(s): Sibutramine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Sibutramine hydrochloride; Assigned to Arm(s): Lead-in sibutramine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Upper Trapezius Myofascial Trigger Points- a Randomized Intervention Study
Brief Summary: In relation to Myofascial Triggerpoints (MFTrPs) of the upper Trapezius, this study will explore muscle contractility characteristics, the occurrence of post-intervention muscle soreness and the effect of dry needling on muscle contractile characteristics and clinical outcomes.


Options:
A: Arm Label: Dry needling (deep); Type: EXPERIMENTAL; Interventions: Procedure: Dry needling | Arm Label: Dry needling (superficial); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Dry needling | Intervention Type: PROCEDURE; Name: Dry needling; Assigned to Arm(s): Dry needling (deep), Dry needling (superficial)
B: Arm Label: Deep dry needling; Type: ACTIVE_COMPARATOR; Interventions: Other: Group 1. Deep dry needling | Arm Label: muscle stretch; Type: OTHER; Interventions: Other: Group 1. Deep dry needling, Other: group 2. Passive analitical stretch (performed in both groups) | Intervention Type: OTHER; Name: Group 1. Deep dry needling; Assigned to Arm(s): Deep dry needling, muscle stretch | Intervention Type: OTHER; Name: group 2. Passive analitical stretch (performed in both groups); Assigned to Arm(s): muscle stretch
C: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Usual care | Arm Label: Integrative care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Integrative care | Intervention Type: PROCEDURE; Name: Integrative care; Assigned to Arm(s): Integrative care | Intervention Type: PROCEDURE; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Standard ED management alone; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard ED management alone | Arm Label: Acupuncture plus standard ED management; Type: EXPERIMENTAL; Interventions: Procedure: Acupuncture plus standard ED management | Intervention Type: PROCEDURE; Name: Acupuncture plus standard ED management; Assigned to Arm(s): Acupuncture plus standard ED management | Intervention Type: PROCEDURE; Name: Standard ED management alone; Assigned to Arm(s): Standard ED management alone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Telemedicine Follow-up Care in Primary Health Care Versus Traditional Follow-up in Specialist Health Care on the Healing Time for Diabetes-related Foot Ulcers - a Cluster-randomized Controlled Trial
Brief Summary: This study will investigate whether telemedicine follow-up care for people with diabetes-related foot ulcers and people with leg ulcers (without diabetes) in municipal primary health care in collaboration with specialist health care is an equivalent alternative to traditional outpatient clinical follow-up in specialist health care (noninferiority trial) in relation to healing time.


Options:
A: Arm Label: Conventional EMS physician; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional EMS physician | Arm Label: Tele-EMS physician; Type: OTHER; Interventions: Other: tele-EMS physician | Intervention Type: OTHER; Name: conventional EMS physician; Assigned to Arm(s): Conventional EMS physician | Intervention Type: OTHER; Name: tele-EMS physician; Assigned to Arm(s): Tele-EMS physician
B: Arm Label: Tertiary care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Primary care; Type: EXPERIMENTAL; Interventions: Other: Telemedicine | Intervention Type: OTHER; Name: Telemedicine; Assigned to Arm(s): Primary care
C: Arm Label: Traditional follow-up; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemedicine follow-up care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Telemedicine follow-up care | Intervention Type: PROCEDURE; Name: Telemedicine follow-up care; Assigned to Arm(s): Telemedicine follow-up care
D: Arm Label: Technology supported supervision; Type: EXPERIMENTAL; Interventions: Other: Technology supported supervision, Other: Integrated community case management | Arm Label: Community supported supervision; Type: EXPERIMENTAL; Interventions: Behavioral: Community supported supervision, Other: Integrated community case management | Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Integrated community case management | Intervention Type: OTHER; Name: Technology supported supervision; Assigned to Arm(s): Technology supported supervision | Intervention Type: BEHAVIORAL; Name: Community supported supervision; Assigned to Arm(s): Community supported supervision | Intervention Type: OTHER; Name: Integrated community case management; Assigned to Arm(s): Community supported supervision, Control arm, Technology supported supervision

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Telemedicine Follow-up Care in Primary Health Care Versus Traditional Follow-up in Specialist Health Care on the Healing Time for Diabetes-related Foot Ulcers - a Cluster-randomized Controlled Trial
Brief Summary: This study will investigate whether telemedicine follow-up care for people with diabetes-related foot ulcers and people with leg ulcers (without diabetes) in municipal primary health care in collaboration with specialist health care is an equivalent alternative to traditional outpatient clinical follow-up in specialist health care (noninferiority trial) in relation to healing time.


Options:
A: Arm Label: Infants at risk; Type: N/A; Interventions: Behavioral: ProAsk | Arm Label: Infants not at risk; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ProAsk; Assigned to Arm(s): Infants at risk
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Health Workers; Type: EXPERIMENTAL; Interventions: Behavioral: community health workers | Intervention Type: BEHAVIORAL; Name: community health workers; Assigned to Arm(s): Community Health Workers
C: Arm Label: Interactive computer-assisted screening; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive computer-assisted screening (iCAS) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interactive computer-assisted screening (iCAS); Assigned to Arm(s): Interactive computer-assisted screening
D: Arm Label: Traditional follow-up; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemedicine follow-up care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Telemedicine follow-up care | Intervention Type: PROCEDURE; Name: Telemedicine follow-up care; Assigned to Arm(s): Telemedicine follow-up care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management
Brief Summary: Randomized controlled trial of intubation using the C-MAC video laryngoscope versus standard laryngoscopy. Patients who are going to be intubated using standard laryngoscopy will be randomized to have their first intubation attempt done using either standard laryngoscopy or the C-MAC video laryngoscope. Subsequent attempts will be at the discretion of the treating physician.


Options:
A: Arm Label: Direct Laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Direct Laryngoscopy | Arm Label: CMAC; Type: EXPERIMENTAL; Interventions: Procedure: CMAC videolaryngoscope | Intervention Type: PROCEDURE; Name: CMAC videolaryngoscope; Assigned to Arm(s): CMAC | Intervention Type: PROCEDURE; Name: Direct Laryngoscopy; Assigned to Arm(s): Direct Laryngoscopy
B: Arm Label: Truview EVO2®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Airtraq®; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Arm Label: Direct laryngoscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes | Intervention Type: OTHER; Name: Macintosh type, Truview EVO2® type and Airtraq® type laryngoscopes; Assigned to Arm(s): Airtraq®, Direct laryngoscopy, Truview EVO2®
C: Arm Label: Macintosh laryngoscope; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Tracheal intubation, Drug: Propofol and remifentanil anesthesia | Arm Label: McGrath Mac videolaryngoscope; Type: EXPERIMENTAL; Interventions: Procedure: Tracheal intubation, Drug: Propofol and remifentanil anesthesia | Intervention Type: PROCEDURE; Name: Tracheal intubation; Assigned to Arm(s): Macintosh laryngoscope, McGrath Mac videolaryngoscope | Intervention Type: DRUG; Name: Propofol and remifentanil anesthesia; Assigned to Arm(s): Macintosh laryngoscope, McGrath Mac videolaryngoscope
D: Arm Label: conventional endotracheal intubation; Type: ACTIVE_COMPARATOR; Interventions: Device: Macintosh blade | Arm Label: C-MAC; Type: ACTIVE_COMPARATOR; Interventions: Device: C-MAC videolaryngoscope | Intervention Type: DEVICE; Name: Macintosh blade; Assigned to Arm(s): conventional endotracheal intubation | Intervention Type: DEVICE; Name: C-MAC videolaryngoscope; Assigned to Arm(s): C-MAC

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Targinact® Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study.
Brief Summary: This non-interventional, observational study evaluates the efficacy of Targinact with regard to quality of life in daily clinical practice in Belgium compared to the previous analgesic treatment.


Options:
A: Arm Label: Targinact® (oxycodon/naloxon); Type: N/A; Interventions: Drug: Targinact® (oxycodon/naloxon) | Intervention Type: DRUG; Name: Targinact® (oxycodon/naloxon); Assigned to Arm(s): Targinact® (oxycodon/naloxon)
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: SC Placebo | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SC Placebo; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 2
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: SC Placebo | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SC Placebo; Assigned to Arm(s): Arm 2
D: Arm Label: Morphine Sulphate; Type: N/A; Interventions: Drug: methylnaltrexone | Arm Label: Fentanyl; Type: N/A; Interventions: Drug: methylnaltrexone | Arm Label: Oxycodone; Type: N/A; Interventions: Drug: methylnaltrexone | Intervention Type: DRUG; Name: methylnaltrexone; Assigned to Arm(s): Fentanyl, Morphine Sulphate, Oxycodone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Targinact® Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study.
Brief Summary: This non-interventional, observational study evaluates the efficacy of Targinact with regard to quality of life in daily clinical practice in Belgium compared to the previous analgesic treatment.


Options:
A: Arm Label: 'Oxycodone/Naloxone'; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Arm Label: Oxycodone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone(single compound) | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): 'Oxycodone/Naloxone' | Intervention Type: DRUG; Name: Oxycodone(single compound); Assigned to Arm(s): Oxycodone
B: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: SC Placebo | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SC Placebo; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 2
D: Arm Label: Targinact® (oxycodon/naloxon); Type: N/A; Interventions: Drug: Targinact® (oxycodon/naloxon) | Intervention Type: DRUG; Name: Targinact® (oxycodon/naloxon); Assigned to Arm(s): Targinact® (oxycodon/naloxon)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exploring the Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease
Brief Summary: To explore the effectiveness and biobehavioural basis of baclofen in improving treatment outcomes for alcohol dependence in people with or without alcoholic cirrhosis in a double-blind randomised placebo-controlled trial.


Options:
A: Arm Label: BACLOFEN; Type: EXPERIMENTAL; Interventions: Drug: BACLOFEN | Arm Label: PLACEBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: PLACEBO | Intervention Type: DRUG; Name: BACLOFEN; Assigned to Arm(s): BACLOFEN | Intervention Type: DRUG; Name: PLACEBO; Assigned to Arm(s): PLACEBO
B: Arm Label: ITB therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: intrathecal baclofen | Arm Label: Best Medical Treatment (BMT); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: intrathecal baclofen; Assigned to Arm(s): ITB therapy
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Baclofen 30mg/day | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Baclofen 75mg/day | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Baclofen 30mg/day; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Baclofen 75mg/day; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3
D: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Baclofen | Intervention Type: DRUG; Name: Baclofen; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exploring the Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease
Brief Summary: To explore the effectiveness and biobehavioural basis of baclofen in improving treatment outcomes for alcohol dependence in people with or without alcoholic cirrhosis in a double-blind randomised placebo-controlled trial.


Options:
A: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Baclofen | Intervention Type: DRUG; Name: Baclofen; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Benfotiamine; Type: EXPERIMENTAL; Interventions: Drug: Benfotiamine | Intervention Type: DRUG; Name: Benfotiamine; Assigned to Arm(s): Benfotiamine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control Group
C: Arm Label: Baclofen; Type: EXPERIMENTAL; Interventions: Drug: Baclofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Baclofen; Assigned to Arm(s): Baclofen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Baclofen 30mg/day | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Baclofen 75mg/day | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Baclofen 30mg/day; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Baclofen 75mg/day; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Observational Study of Male Circumcision Using the PrePex Device in Routine Clinical Settings in Kenya
Brief Summary: The study will measure the incidence of moderate and severe adverse events (AEs) associated with PrePex procedures, including both procedural and post-procedure events, and all device-related incidents such as dislodgment. To assure complete ascertainment of AEs, study-specific forms will be used to collect standardized data from the circumcision visit and all follow-up visits. Follow-up will be more intensive for the first 50 cases, and will revert to routine practice (two follow-up visits) for the remaining 375 cases.


Options:
A: Arm Label: PrePex™ device; Type: EXPERIMENTAL; Interventions: Device: PrePex™ device for adult male circumcision | Arm Label: Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical circumcision | Intervention Type: DEVICE; Name: PrePex™ device for adult male circumcision; Assigned to Arm(s): PrePex™ device | Intervention Type: PROCEDURE; Name: Surgical circumcision; Assigned to Arm(s): Surgical
B: Arm Label: Circumcised immediately; Type: ACTIVE_COMPARATOR; Interventions: Procedure: male circumcision | Arm Label: Delayed Circumcision; Type: PLACEBO_COMPARATOR; Interventions: Procedure: male circumcision | Intervention Type: PROCEDURE; Name: male circumcision; Assigned to Arm(s): Circumcised immediately, Delayed Circumcision
C: Intervention Type: DEVICE; Name: PrePex device for male circumcision; Assigned to Arm(s): N/A
D: Intervention Type: PROCEDURE; Name: Male Circumcision; Assigned to Arm(s): N/A

Answer: C